SCHW · Insider Trading
The Charles Schwab Corporation
Every open-market purchase and sale reported by SCHW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Charles A. Ruffel | Director | A | +1,222 deriv. | — |
| 2026-10-05 | Stephen A Ellis | Director | A | +369 deriv. | — |
| 2026-10-05 | Frank C Herringer | Director | A | +445 deriv. | — |
| 2026-10-05 | Marianne Catherine Brown | Director | A | +407 deriv. | — |
| 2026-10-05 | Neesha Hathi | MD, Head Wealth Adv, Bnk, Tst | MIXED | — | −$279.11K |
| 2026-09-25 | Stephen A Ellis | Director | M | +1,918 | +$60.38K |
| 2026-09-02 | Neesha Hathi | MD, Head Wealth Adv, Bnk, Tst | MIXED | — | −$181.07K |
| 2026-08-31 | Walter W Bettinger | Co-Chairman | MIXED | — | −$4.77M |
| 2026-08-31 | Neesha Hathi | MD, Head Wealth Adv, Bnk, Tst | MIXED | — | −$178.13K |
| 2026-08-28 | Charles R. Schwab | Co-Chairman | G | −9,300 | — |
| 2026-08-27 | Carolyn Schwab-Pomerantz | Director | Sell | −9,175 | −$1.00M |
| 2026-08-26 | Charles R. Schwab | Co-Chairman | Sell | −117,000 | −$13.24M |
| 2026-08-26 | Walter W Bettinger | Co-Chairman | MIXED | — | −$11.75M |
| 2026-08-19 | Charles R. Schwab | Co-Chairman | G | −100,050 | — |
| 2026-08-18 | Jonathan S Beatty | MD, Head of Advisor Services | Sell | −1,000 | −$111.33K |
| 2026-08-17 | Dennis Howard | MD, Chief Tech, OPS & Data Off | Sell | −2,198 | −$241.78K |
| 2026-08-17 | Jonathan M. Craig | MD, Head of Retail Investing | MIXED | — | −$1.40M |
| 2026-08-13 | Charles R. Schwab | Co-Chairman | Sell | −46,410 | −$5.02M |
| 2026-08-11 | Charles R. Schwab | Co-Chairman | Sell | −46,445 | −$5.01M |
| 2026-08-10 | Nigel J Murtagh | Chief Risk Officer | MIXED | — | −$1.66M |
| 2026-08-10 | Charles R. Schwab | Co-Chairman | G | −37,200 | — |
| 2026-08-10 | Paula A Sneed | Director | Sell | −5,263 | −$563.95K |
| 2026-08-07 | Carolyn Schwab-Pomerantz | Director | Sell | −18,561 | −$2.00M |
| 2026-08-07 | Jonathan M. Craig | MD, Head of Retail Investing | MIXED | — | −$1.31M |
| 2026-08-07 | Jonathan M. Craig | MD, Head of Retail Investing | MIXED | — | −$1.31M |
| 2026-08-07 | Carolyn Schwab-Pomerantz | Director | Sell | −18,561 | −$2.00M |
| 2026-08-05 | Carolyn Schwab-Pomerantz | Director | Sell | −22,640 | −$2.41M |
| 2026-08-04 | Dennis Howard | MD, Chief Tech, OPS & Data Off | F | −1,292 | −$135.49K |
| 2026-08-04 | Charles R. Schwab | Co-Chairman | Sell | −142,900 | −$15.10M |
| 2026-07-30 | Dennis Howard | MD, Chief Tech, OPS & Data Off | MIXED | — | −$1.15M |
| 2026-07-30 | Charles R. Schwab | Co-Chairman | MIXED | −203,450 | −$15.17M |
| 2026-07-30 | Carolyn Schwab-Pomerantz | Director | MIXED | −22,921 | −$2.39M |
| 2026-07-29 | Nigel J Murtagh | Chief Risk Officer | MIXED | — | −$1.88M |
| 2026-07-29 | Walter W Bettinger | Co-Chairman | MIXED | — | −$14.89M |
| 2026-07-28 | Charles R. Schwab | Co-Chairman | Sell | −45,500 | −$4.63M |
| 2026-07-27 | Peter J. Morgan III | General Counsel | Sell | −6,952 | −$709.34K |
| 2026-07-23 | Nigel J Murtagh | Chief Risk Officer | MIXED | — | −$232.35K |
| 2026-07-21 | Jonathan S Beatty | MD, Head of Advisor Services | Sell | −2,000 | −$208.41K |
| 2026-07-09 | Jonathan M. Craig | MD, Head of Retail Investing | MIXED | — | −$1.20M |
| 2026-07-08 | Jonathan S Beatty | MD, Head of Advisor Services | Sell | −2,000 | −$204.02K |
| 2026-07-06 | Frank C Herringer | Director | A | +457 deriv. | — |
| 2026-07-06 | Marianne Catherine Brown | Director | A | +418 deriv. | — |
| 2026-07-06 | Stephen A Ellis | Director | A | +379 deriv. | — |
| 2026-07-06 | Charles A. Ruffel | Director | A | +1,280 deriv. | — |
| 2026-07-06 | Jonathan S Beatty | MD, Head of Advisor Services | MIXED | −5,036 | −$490.14K |
| 2026-06-25 | Stephen A Ellis | Director | M | +2,258 | +$56.70K |
| 2026-06-04 | Michael D Verdeschi | CFO | F | −6,519 | −$569.89K |
| 2026-05-28 | Richard A Wurster | President & CEO | Buy | +21,959 | +$1.85M |
| 2026-05-28 | Joan Dea | Director | A | +1,602 | — |
| 2026-05-28 | Carolyn Schwab-Pomerantz | Director | A | +1,602 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Charles R. Schwab | Co-Chairman | 30,021,463 | $2.76B |
| Todd M Ricketts | Director | 535,134 | $49.21M |
| Christopher V Dodds | Director | 456,323 | $41.96M |
| Richard A Wurster | President & CEO | 223,004 | $20.51M |
| Walter W Bettinger | Co-Chairman | 141,933 | $13.05M |
| Stephen A Ellis | Director | 111,655 | $10.27M |
| Paula A Sneed | Director | 101,386 | $9.32M |
| Frank C Herringer | Director | 62,893 | $5.78M |
| Nigel J Murtagh | Chief Risk Officer | 60,593 | $5.57M |
| Paul V Woolway | MD, Chief Banking Officer | 55,019 | $5.06M |
| John K Adams Jr | Director | 50,711 | $4.66M |
| Michael D Verdeschi | CFO | 47,442 | $4.36M |
| Jonathan S Beatty | MD, Head of Advisor Services | 43,197 | $3.97M |
| Arun Sarin | Director | 36,251 | $3.33M |
| Joan Dea | Director | 28,440 | $2.62M |
| Marianne Catherine Brown | Director | 17,353 | $1.60M |
| Charles A. Ruffel | Director | 14,908 | $1.37M |
| Gerri Martin-Flickinger | Director | 14,222 | $1.31M |
| Carolyn Schwab-Pomerantz | Director | 14,024 | $1.29M |
| Bharat Masrani | Director | 7,279 | $669.38K |
| Dennis Howard | MD, Chief Tech, OPS & Data Off | 6,980 | $641.88K |
| Neesha Hathi | MD, Head Wealth Adv, Bnk, Tst | 5,770 | $530.61K |
| Peter J. Morgan III | General Counsel | 697 | $64.10K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SCHW quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.